000 | 01382 a2200397 4500 | ||
---|---|---|---|
005 | 20250513193549.0 | ||
264 | 0 | _c19991116 | |
008 | 199911s 0 0 fre d | ||
022 | _a0003-3898 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSeilles, E | |
245 | 0 | 0 |
_a[Biology of the papillomavirus infections: V. Vaccine developments]. _h[electronic resource] |
260 |
_bAnnales de biologie clinique _c |
||
300 |
_a517-24 p. _bdigital |
||
500 | _aPublication Type: English Abstract; Journal Article; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntibodies, Viral _xtherapeutic use |
650 | 0 | 4 | _aCytotoxicity, Immunologic |
650 | 0 | 4 |
_aDNA, Viral _xanalysis |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aOncogene Proteins _ximmunology |
650 | 0 | 4 |
_aPapillomaviridae _xgenetics |
650 | 0 | 4 |
_aPapillomavirus Infections _xprevention & control |
650 | 0 | 4 | _aPapillomavirus Vaccines |
650 | 0 | 4 |
_aPrecancerous Conditions _xprevention & control |
650 | 0 | 4 |
_aT-Lymphocytes, Cytotoxic _ximmunology |
650 | 0 | 4 |
_aTumor Virus Infections _xprevention & control |
650 | 0 | 4 |
_aUterine Cervical Neoplasms _xprevention & control |
650 | 0 | 4 | _aVaccination |
650 | 0 | 4 |
_aViral Proteins _ximmunology |
650 | 0 | 4 | _aViral Vaccines |
700 | 1 | _aRiethmuller, D | |
700 | 1 | _aMougin, C | |
773 | 0 |
_tAnnales de biologie clinique _gvol. 57 _gno. 5 _gp. 517-24 |
|
999 |
_c10475103 _d10475103 |